Oncolytics Biotech Inc ONCY

Kirk Look to speak today

[Quentin30]

That's just what we want, a non-scientist talking at a fireside chat about Pela's development. Perhaps he will share how he intends to pay for this next Phase II trial...

and bear in mind folks, the data may not facilitate AA.. and thus we will be into Phase III territory...

Interesting that the PanCAn trial was going to save ONCY about 40 million... Matt's words...  half the cost it would normally be...

So, since mBC won't have the comparator arm study already done... we're looking at 80 million again... that's more than ONCY is worth... if anyone is attending, do ask Kirky how he will fund two phase III's without a partner?

oooh wait, there is a partner... Adlai Nortye... who no longer list Pela in their pipeline... and they completed theoir bridging trial in Jun 2023... I wonder why they aren't running a Phase III for China or even mentioning it anymore.

Hands up if you think the PPS will rise after the call... or will it drop as it normally does... meanwhile Palantir is in the S&P 500... hoozah for great companies with clever management.

[jh1970]

Kirk mentioned Accelerated Approval concept .

[Noteable]

Kirk Look also said the following - " ... we are on the cusp of the (Bracelet-1) overall survival (OS) data. We will expect that to be announced imminently .... "

[Noteable]

Look aslo said this - " ... What we presented to the FDA was a Phase 2 concept, kind of using the receipe that's been used [before], you know, quite a few times. Ibrance is a good example in HER2 as well as a good example of how a Phase 2 the size of 180-200 patients can be powered in a manner that if you reach cerftain endpoints, that the powering is sufficient to seek accelerated

[CMHarring218431]

Well, there you go....presenting pertinent information.LOL The quotes from Kirk Look are much appreciated. Confidence restored! Thanks

[Quentin30]

do you mean, like the comment that they have had the data since MAY... and it's taken them 4 months to assess this. Good Lord they only had 48 patients to begin with... and that's divided into thirds per cohort...  market seems excited though, only down 2 1/2 %

[Noteable]

It's obvious that you Qurntin30 Koffey, didn't listen to what Look said today regarding the maturing OS and how and when it will be reported. So go talk to your buddy CMHarrington, and maybe he will explain it for you.

[Noteable]

Just to remind everyone Quentin30 said he doesn't hold any shares I'm ONCY  so why should he worry about any impending developments.Yet he's posting as though he does.

[Quentin30]

I WAS invested in ONCY for 20 years... finally got very tired of waiting for the 'pivotal' year. Brad's timelines were fantasy, as were Matt's... and now Kirk..? There is potential here... but to date management have incapable of demonstrating this, the market cap is testament to this... the reason for questioning the true 'pivot' point is HOW do they get to that point

[CMHarring218431]

I'm Quentin 's buddy??? How the hell did you arrive at that??? That's a reach. Now, because you are so far off in your assessment me, I don't know what to believe when you post. A few months back, you also accused me of being a friend to one of these clowns. Forget the compliments I sent your way....even if you are the former ceo. 

[Noteable]

This post has been removed in accordance with Community Policy

[Peladawn]

And outright blatant lying to the American people as a an operational norm are best left to the Kamalamebrain Harris disaster in the making.

[Peladawn]

This post has been removed in accordance with Community Policy

[Peladawn]

This post has been removed in accordance with Community Policy

[Noteable]

As I've already said  .. I don't really care what you think.  Pandering, vanity, ego and the lack of character are best left for those in DJT's camp, and you've just proved my point.

[Noteable]

So in response to those who don't own any stock in this company but are obsessed with posting their obscure opinions here  ... and as I have already posted .. ..By ONCY beginning the process of enrolling between 180-200 patients in a monotherapy pelareorep + paclitaxel clinical/registration study ONCY speeds up the Accelerated Approval process by demonstrating to the FDA that ONCY is well

[Peladawn]

This post has been removed in accordance with Community Policy

[Peladawn]

...and I have absolutely no doubt, that now you will try to paint me as an evil person, when in fact it is you who has supported the untold violence against innocent Americans, Ukrainians, and Jews alike because of the blatant stupidity, incompetence, and greed of your candidate and her minions.

[Noteable]

As I have to keep reposting ..I don't really care what you think. Pandering, vanity, ego and the lack of character are best left for those in DJT's camp.

[Angler101]

Lol....like I said...."sharp as a tack"....you'll get your karma

[venture009]

Then based on this comment re utilizing 180 to 200 patients to seek accelerated approval, we are months and perhaps a couple of years away from even entetaining seeking AA. In the mean time how are these trials going to be financed unless a partner steps forward or a buyout. OS may be the catalyst, especially since one of the concerns of pela is it's ability to last any length of time. The